Entrada Therapeutics Inc (TRDA)

17.41 -0.33 (-1.86%) USD  |  NASDAQ  |  Dec 27, 16:00
17.47 +0.06 (+0.34%) After-Hours: 20:00
More

Entrada Therapeutics Cash and Short Term Investments (Annual): 351.97M for Dec. 31, 2023

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for TRDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Catalyst Pharmaceuticals Inc 137.64M
Vertex Pharmaceuticals Inc 11.22B
Sarepta Therapeutics Inc 1.676B
Regenxbio Inc 275.26M
Edgewise Therapeutics Inc 318.39M